Zobrazeno 1 - 10
of 223
pro vyhledávání: '"Andrew J. Nunn"'
Autor:
Stella M. Fabiane, Chen-Yuan Chiang, Sarah K. Meredith, Meera Gurumurthy, Adamu Bayissa, Andrew J. Nunn, Ruth L. Goodall
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 9, Iss 9, p 211 (2024)
(1) Background: The World Health Organisation (WHO) categorises moxifloxacin and levofloxacin as Group A drugs, which should be prioritised in the treatment of rifampicin-resistant tuberculosis. We compare their relative efficacy and safety using dat
Externí odkaz:
https://doaj.org/article/c22ca3ecff6d4e1e806bc6732c2ab81a
Autor:
Santhanalakshmi Gengiah, Catherine Connolly, Nonhlanhla Yende-Zuma, Pierre M. Barker, Andrew J. Nunn, Nesri Padayatchi, Myra Taylor, Marian Loveday, Kogieleum Naidoo
Publikováno v:
Implementation Science, Vol 16, Iss 1, Pp 1-16 (2021)
Abstract Background A quality improvement (QI) collaborative approach to enhancing integrated HIV-Tuberculosis (TB) services may be effective in scaling up and improving the quality of service delivery. Little is known of the role of organizational c
Externí odkaz:
https://doaj.org/article/54532b662196469f95eb3e61b6924d7e
Autor:
Santhanalakshmi Gengiah, Pierre M. Barker, Nonhlanhla Yende‐Zuma, Mduduzi Mbatha, Shane Naidoo, Myra Taylor, Marian Loveday, Mesuli Mhlongo, Clark Jackson, Andrew J. Nunn, Nesri Padayatchi, Salim S. Abdool Karim, Kogieleum Naidoo
Publikováno v:
Journal of the International AIDS Society, Vol 24, Iss 9, Pp n/a-n/a (2021)
Abstract Introduction : Tuberculosis (TB) remains the most common cause of death among people living with HIV. Integrating HIV and TB services reduces mortality but is sub‐optimally implemented. Quality improvement (QI) methods offer a low‐cost a
Externí odkaz:
https://doaj.org/article/3b6b6adedeb74fc1978ca6e52f52ba0e
Autor:
Conor D. Tweed, Angela M. Crook, Rodney Dawson, Andreas H. Diacon, Timothy D. McHugh, Carl M. Mendel, Sarah K. Meredith, Lerato Mohapi, Michael E. Murphy, Andrew J. Nunn, Patrick P. J. Phillips, Kasha P. Singh, Melvin Spigelman, Stephen H. Gillespie
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background The phase III REMoxTB study prospectively enrolled HIV-positive (with CD4+ count > 250 cells, not on anti-retroviral therapy) and HIV-negative patients. We investigated the incidence of adverse events and cure rates according to H
Externí odkaz:
https://doaj.org/article/d4f6503cd6b943dbb18e73105c9b0eb8
Autor:
Conor D. Tweed, Angela M. Crook, Evans I. Amukoye, Rodney Dawson, Andreas H. Diacon, Madeline Hanekom, Timothy D. McHugh, Carl M. Mendel, Sarah K. Meredith, Michael E. Murphy, Saraswathi E. Murthy, Andrew J. Nunn, Patrick P. J. Phillips, Kasha P. Singh, Melvin Spigelman, Genevieve H. Wills, Stephen H. Gillespie
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background The incidence and severity of tuberculosis chemotherapy toxicity is poorly characterised. We used data available from patients in the REMoxTB trial to provide an assessment of the risks associated with the standard regimen and two
Externí odkaz:
https://doaj.org/article/87ffe9cc14bf494197dd9d05a700110f
Autor:
Conor Duncan Tweed, Genevieve Helen Wills, Angela M. Crook, Rodney Dawson, Andreas H. Diacon, Cheryl E. Louw, Timothy D. McHugh, Carl Mendel, Sarah Meredith, Lerato Mohapi, Michael E. Murphy, Stephen Murray, Sara Murthy, Andrew J. Nunn, Patrick P. J. Phillips, Kasha Singh, M. Spigelman, S. H. Gillespie
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-10 (2018)
Abstract Background Drug-induced liver injury (DILI) is a common complication of tuberculosis treatment. We utilised data from the REMoxTB clinical trial to describe the incidence of predisposing factors and the natural history in patients with liver
Externí odkaz:
https://doaj.org/article/9c5b8d40012f497db02bc3f9607be6f2
Autor:
Patrick P. J. Phillips, Carl M. Mendel, Andrew J. Nunn, Timothy D. McHugh, Angela M. Crook, Robert Hunt, Anna Bateson, Stephen H. Gillespie
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-9 (2017)
Abstract Background Tuberculosis kills more people than any other infectious disease, and new regimens are essential. The primary endpoint for confirmatory phase III trials for new regimens is a composite outcome that includes bacteriological treatme
Externí odkaz:
https://doaj.org/article/41b6224a176d4f7e8c044ded9a5e8eb4
Autor:
Michael E. Murphy, Patrick P. J. Phillips, Carl M. Mendel, Emily Bongard, Anna L. C. Bateson, Robert Hunt, Saraswathi Murthy, Kasha P. Singh, Michael Brown, Angela M. Crook, Andrew J. Nunn, Sarah K. Meredith, Marc Lipman, Timothy D. McHugh, Stephen H. Gillespie, On behalf of the REMoxTB Consortium
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-10 (2017)
Abstract Background The use of early morning sputum samples (EMS) to diagnose tuberculosis (TB) can result in treatment delay given the need for the patient to return to the clinic with the EMS, increasing the chance of patients being lost during the
Externí odkaz:
https://doaj.org/article/6ed07cb9f278456d91f517953c95470c
Autor:
Nicholas I. Paton, Christopher Cousins, Celina Suresh, Erlina Burhan, Ka Lip Chew, Victoria B. Dalay, Qingshu Lu, Tutik Kusmiati, Vincent M. Balanag, Shu Ling Lee, Rovina Ruslami, Yogesh Pokharkar, Irawaty Djaharuddin, Jani J.R. Sugiri, Rholine S. Veto, Christine Sekaggya-Wiltshire, Anchalee Avihingsanon, Rohit Sarin, Padmasayee Papineni, Andrew J. Nunn, Angela M. Crook
Publikováno v:
New England Journal of Medicine. 388:873-887
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2aa4ca03cba1dad382bfb86babc249e
https://doi.org/10.1056/nejmoa2212537
https://doi.org/10.1056/nejmoa2212537
Autor:
Carole D. Mitnick, Andrew J. Nunn
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 207:1269-1270
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f82989fdfc7f3280d1d3b070718ba25
https://doi.org/10.1164/rccm.202303-0430ed
https://doi.org/10.1164/rccm.202303-0430ed